FIELD: chemistry.
SUBSTANCE: invention concerns new tricyclic derivatives of the formula (I) and their pharmaceutically acceptable salts, where: 1 to 3 of A1, A2, A3 and A4 are nitrogen atoms, while the rest are -CH- groups; G1 is a group selected out of -CH2-O-, -CH2-CH2-, - CH=CH-; -N(C1-C4alkyl)-CH2; G2 is a group selected out of -O-CH2-, -CH=CH-, -CH2- CH2-; R4 can be identical or different and are selected out of a group including hydrogen or halogen atoms; p are independently equal to 0, 1 or 2; Y is and optionally substituted residuum selected out of the group of alkyl, cycloalkyl, alkylaryl, alkylcycloalkylalkyl; Z is a tetrazolyl, -COOR5, -CONR5R5, NHSO2R5 or -CONHSO2R5 group, where R5 is hydrogen or optionally substituted alkyl or aryl. The invention also concerns a method of obtaining the claimed compounds.
EFFECT: possible application in treatment and prophylactics of inflammation and allergy diseases.
20 cl, 2 tbl, 46 ex
Title | Year | Author | Number |
---|---|---|---|
NON-PEPTIDE ANTAGONISTS GnRH | 2003 |
|
RU2329251C2 |
OXAZOLIDINE ANTIBIOTICS | 2008 |
|
RU2470022C2 |
HETEROCYCLIC CONDENSED COMPOUNDS USEFUL AS ANTIDIURETIC AGENTS | 2005 |
|
RU2359969C2 |
SELECTIVE HISTAMINE H4 RECEPTOR ANTAGONISTS FOR TREATING VESTIBULAR DISORDERS | 2009 |
|
RU2589846C2 |
DERIVATIVES OF TRIARYL-CONTAINING ACIDS AS OF PPAR RECEPTOR LIGANDS | 2000 |
|
RU2278860C2 |
BENZAMIDE DERIVATIVES AS OXYTOCIN AGONISTS AND VASOPRESSIN ANTAGONISTS | 2004 |
|
RU2340617C2 |
HETEROCYCLIC COMPOUNDS AND THEIR APPLICATION AS GLYCOGEN SYNTHASE KINASE-3 INHIBITORS | 2011 |
|
RU2623427C2 |
5-AMINO-2-(1-HYDROXYETHYL)TETRAHYDROPYRAN DERIVATIVES | 2009 |
|
RU2525541C2 |
NEW DERIVATIVES OF AMINOCYCLOHEXANE | 2001 |
|
RU2225393C1 |
PHENOXYMETHYL DERIVATIVES | 2016 |
|
RU2746481C1 |
Authors
Dates
2008-08-10—Published
2003-11-11—Filed